Need to invest in new HIV prevention methods remains 'urgent,' International Microbicides Conference hears

"Although the research for new HIV prevention technologies has indeed made some progress, ... a formidable way lies ahead to find enough money to finish the research and to make 'from discovery to delivery' a reality for those in need of protecting themselves from HIV," CNS/ reports. "This issue of health financing of new HIV prevention technologies was in spotlight at the closing day plenary of the International Microbicides Conference (M2012) in Sydney, Australia," the news service adds.

"'[T]he need to invest in new HIV prevention methods remains urgent and necessary,' said Dr. Debrework Zewdie, deputy general manager and head of" the Global Fund to Fight AIDS, Tuberculosis and Malaria's strategy, investment and impact division, the news service writes. "Zewdie added: 'Today, more than 30 years after the start of the AIDS epidemic, we have more tools to prevent the disease than ever before. But are these all the tools we need and are they accessible to all in need?'" according to the news service. The article discusses the lag time between discovery and delivery of prevention technologies, barriers to access to these technologies, funding gaps, and the cost of bringing a drug or technology from development to market (Ramakant, 4/19).

http://www.kaiserhealthnews.orgThis article was reprinted from with permission from the Henry J. Kaiser Family Foundation. Kaiser Health News, an editorially independent news service, is a program of the Kaiser Family Foundation, a nonpartisan health care policy research organization unaffiliated with Kaiser Permanente.


The opinions expressed here are the views of the writer and do not necessarily reflect the views and opinions of News Medical.
Post a new comment

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.

You might also like...
WHO report highlights rising STI rates and insufficient progress in HIV and hepatitis control